EFFECTS OF ATORVASTATIN-FENOFIBRATE COMBINATION COMPARED TO ATORVASTATIN MONOTHERAPY ON LIPID PROFILE IN PATIENTS WITH COMBINED DYSLIPIDEMIA

被引：0
|
作者：
Derosa, G. [1 ]
Salvadeo, S. [1 ]
Ferrari, I. [1 ]
Cicero, A. [2 ]
机构：
[1] Univ Pavia, I-27100 Pavia, Italy
[2] Univ Bologna, Clin Med & Appl Biotechnol Dept, Bologna, Italy
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia
    Athyros, VG
    Papageorgiou, AA
    Athyrou, VV
    Demitriadis, DS
    Kontopoulos, AG
    DIABETES CARE, 2002, 25 (07) : 1198 - 1202
  • [22] Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipidemia
    Kostapanos, Michael S.
    Elisaf, Moses S.
    Mikhailidis, Dimitri P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (04) : 427 - 427
  • [23] Effect of Atorvastatin Monotherapy and Low-Dose Atorvastatin/Ezetimibe Combination on Fasting and Postprandial Triglycerides in Combined Hyperlipedemia
    Lee, Sang-Hak
    Park, Sungha
    Kang, Seok-Min
    Jang, Yangsoo
    Chung, Namsik
    Choi, Donghoon
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2012, 17 (01) : 65 - 71
  • [24] Fenofibrate, but not atorvastatin treatment increases homocystein levels in patients with combined hyperlipidaemia
    Melenovsky, V
    Malik, J
    Wichterle, D
    Simek, J
    Ceska, R
    Parizkova, A
    EUROPEAN HEART JOURNAL, 2000, 21 : 636 - 636
  • [25] Fenofibrate and atorvastatin in patients with combined hyperlipidemia and dense low density lipoproteins
    Weltzien, P
    Winkler, K
    Friedrich, I
    Schmitz, H
    Hauck, P
    Hoffmann, M
    Baumstark, M
    Wieland, H
    März, W
    DIABETOLOGIA, 2002, 45 : A389 - A389
  • [26] Efficacy and Safety of Alternate Day Therapy With Atorvastatin and Fenofibrate Combination in Mixed Dyslipidemia A Randomized Controlled Trial
    Harivenkatesh, Natarajan
    David, Darling Chellathai
    Haribalaji, Natarajan
    Sudhakar, Muthiah Kothandaramanujam
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (03) : 296 - 303
  • [27] Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy
    Insull, William, Jr.
    Toth, Peter P.
    Superko, H. Robert
    Thakkar, Roopal B.
    Krause, Scott
    Jiang, Ping
    Parreno, Rhea A.
    Padley, Robert J.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 1065 - 1075
  • [28] Atorvastatin Combined Nitroglycerin Therapy Confer Additive Effects on Rabbits with Dyslipidemia
    Yang, Fang
    Wang, Jindong
    Li, Fei
    Cui, Lei
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2016, 124 (06) : 367 - 371
  • [29] Tesaglitazar as add-on therapy to atorvastatin further improves the lipid profile in subjects with dyslipidemia
    Tonstad, S.
    Retterstol, K.
    Ose, L.
    Ohman, P.
    Lindberg, M.
    Svensson, M.
    DIABETES, 2006, 55 : A135 - A136
  • [30] Effects of pitavastatin and atorvastatin on lipoprotein oxidation biomarkers in patients with dyslipidemia
    Yoshida, Hiroshi
    Shoda, Toru
    Yanai, Hidekatsu
    Ikewaki, Katsunori
    Kurata, Hideaki
    Ito, Kumie
    Furutani, Nobuyuki
    Tada, Norio
    Witztum, Joseph L.
    Tsimikas, Sotirios
    ATHEROSCLEROSIS, 2013, 226 (01) : 161 - 164
12345